Methylnaltrexone potentiates body weight and fat reduction with leptin

Journal of Opioid Management

Volumn 5, Issue 6, 2009, Pages 373-378

  Yuan, Chun Su ^a   Sun, Shi ^a   Attele, Anoja ^a   Wang, Chong Zhi ^a   Tong, Robin ^a   Israel, Robert J ^b  

^a UNIVERSITY OF CHICAGO   (United States)

^b A Subsidiary of Lantheus Holdings   (United States)

Author keywords

Adipose tissue; Body weight; Leptin; Methylnaltrexone; Naloxone; Neonatal rat; Opioids

Indexed keywords

17 METHYLNALTREXONE; LEPTIN; NALOXONE; DRUG DERIVATIVE; NALTREXONE; NARCOTIC ANTAGONIST; QUATERNARY AMMONIUM DERIVATIVE;

ANIMAL EXPERIMENT; ARTICLE; BODY FAT; BODY WEIGHT; CONTROLLED STUDY; DRUG POTENTIATION; FEMALE; MALE; NEWBORN; NONHUMAN; RAT; WEIGHT GAIN; WEIGHT REDUCTION; ANIMAL; DRUG EFFECT; HISTOLOGY; INTRAABDOMINAL FAT; INTRAPERITONEAL DRUG ADMINISTRATION; OBESITY; SPRAGUE DAWLEY RAT; TIME;

ADIPOSITY; ANIMALS; ANIMALS, NEWBORN; DRUG SYNERGISM; INJECTIONS, INTRAPERITONEAL; INTRA-ABDOMINAL FAT; LEPTIN; NALTREXONE; NARCOTIC ANTAGONISTS; QUATERNARY AMMONIUM COMPOUNDS; RATS; RATS, SPRAGUE-DAWLEY; TIME FACTORS; WEIGHT LOSS;

EID: 75649129392     PISSN: 15517489     EISSN: None     Source Type: Journal    
DOI: 10.5055/jom.2009.0037     Document Type: Article

References (29)

1. Jequier E: Leptin signaling, adiposity, and energy balance. Ann N Y Acad Sci. 2002; 967: 379-388.
2. Arora S, Anubhuti: Role of neuropeptides in appetite regulation and obesity - A review. Neuropeptides. 2006; 40: 375-401.
3. Zhang Y, Proenca R, Maffei M, et al.: Positional cloning of the mouse obese gene and its human homologue. Nature. 1994; 372: 425-432.
4. Campfield LA, Smith FJ, Guisez Y, et al.: Recombinant mouse OB protein: Evidence for a peripheral signal linking adiposity and central neural networks. Science. 1995; 269: 546-549.
5. Attele AS, Shi ZQ, Yuan CS: Leptin, gut, and food intake. Biochem Pharmacol. 2002; 63: 1579-1583.
6. Wiwanitkit V: Interaction between leptin and leptin receptor in gastric carcinoma: gene ontology analysis. Rev Esp Enferm Dig. 2007; 99: 201-205.
7. Yuan CS, Attele AS, Dey L, et al.: Gastric effects of cholecystokinin and its interaction with leptin on brainstem neuronal activity in neonatal rats. J Pharmacol Exp Ther. 2000; 295: 177-182.
8. Yuan CS, Dey L, Xie JT, et al.: Gastric effects of galanin and its interaction with leptin on brainstem neuronal activity. J Pharmacol Exp Ther. 2002; 301: 488-493.
9. Shi ZQ, Nelson A, Whitcomb L, et al.: Intracerebroventricular administration of leptin markedly enhances insulin sensitivity and systemic glucose utilization in conscious rats. Metabolism. 1998; 47: 1274-1280.
10. Wang JL, Chinookoswong N, Scully S, et al.: Differential effects of leptin in regulation of tissue glucose utilization in vivo. Endocrinology. 1999; 140: 2117-2124.
11. Halaas JL, Gajiwala KS, Maffei M, et al.: Weight-reducing effects of the plasma protein encoded by the obese gene. Science. 1995; 269: 543-546.
12. Yuan CS, Attele AS, Zhang L, et al.: Leptin reduces body weight gain in neonatal rats. Pediatr Res. 2000; 48: 380-383.
13. Ahima RS, Antwi DA: Brain regulation of appetite and satiety. Endocrinol Metab Clin North Am. 2008; 37: 811-823.
14. Kotz CM, Grace MK, Briggs J, et al.: Effects of opioid antagonists naloxone and naltrexone on neuropeptide Y-induced feeding and brown fat thermogenesis in the rat. Neural site of action. J Clin Invest. 1995; 96: 163-170.
15. Appleyard SM, Hayward M, Young JI, et al.: A role for the endogenous opioid beta-endorphin in energy homeostasis. Endocrinology. 2003; 144: 1753-1760.
16. Cao WH, Morrison SF: Brown adipose tissue thermogenesis contributes to fentanyl-evoked hyperthermia. Am J Physiol Regul Integr Comp Physiol. 2005; 288: R723-R732.
17. Yuan CS: Methylnaltrexone mechanisms of action and effects on opioid bowel dysfunction and other opioid adverse effects. Ann Pharmacother. 2007; 41: 984-993.
18. Ravishankar Ram M, Beena G, Ragunathan P, et al.: Analysis of structure, function, and evolutionary origin of the ob gene product-leptin. J Biomol Struct Dyn. 2007; 25: 183-188.
19. Bado A, Levasseur S, Attoub S, et al.: The stomach is a source of leptin. Nature. 1998; 394: 790-793.
20. Mix H, Manns MP, Wagner S, et al.: Expression of leptin and its receptor in the human stomach. Gastroenterology. 1999; 117: 509.
21. Hukshorn CJ, Saris WH: Leptin and energy expenditure. Curr Opin Clin Nutr Metab Care. 2004; 7: 629-633.
22. Dhillo WS: Appetite regulation: An overview. Thyroid. 2007; 17: 433-445.
23. Cramer CP, Blass EM: Mechanisms of control of milk intake in suckling rats. Am J Physiol. 1983; 245: R154-R159.
24. Bernardis LL, Bellinger LL: The dorsomedial hypothalamic nucleus revisited: 1998 update. Proc Soc Exp Biol Med. 1998; 218: 284-306.
25. Himms-Hagen J, Ricquier D: Brown adipose tissue. In Bray GA, James WPT (ed.): Hand-book of Obesity, New York: Marcel Decker, 1997: 415-432.
26. Cozzolino D, Sessa G, Salvatore T, et al.: The involvement of the opioid system in human obesity: A study in normal weight relatives of obese people. J Clin Endocrinol Metab. 1996; 81: 713-718.
27. Shalev U, Yap J, Shaham Y: Leptin attenuates acute food deprivation-induced relapse to heroin seeking. J Neurosci. 2001; 21: RC129.
28. Baile CA, McLaughlin CL, Della-Fera MA: Role of cholecystokinin and opioid peptides in control of food intake. Physiol Rev. 1986; 66: 172-234.
29. Yuan CS, Israel RJ: Methylnaltrexone: A peripherally acting opioid antagonist. In Dean R, Bilsky EJ, Negus SS (eds.): Opiate Receptors and Antagonists. New York, NY: Humana Press, 2009: 175-198.